Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Biologics

American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing

Staff  |  August 8, 2012

The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.

Filed under:Biologics/DMARDsDrug UpdatesFrom the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)BiologicsdrugLegislationrheumatologist

Managing an In-Office Infusion Practice

Staff  |  August 8, 2012

The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.

Filed under:Billing/CodingBiologics/DMARDsDrug UpdatesFrom the CollegePractice SupportWorkforce Tagged with:AC&RAmerican College of Rheumatology (ACR)BillingBiologicsCodingInfusionpatient carePractice Managementrheumatologiststaffing

Where the Presidential Candidates Stand on Key Healthcare Issues

Michael O'Neal  |  August 8, 2012

Where President Obama and and Republican presidential candidate Mitt Romney stand on healthcare issues affecting rheumatologists and the medical profession as a whole.

Filed under:Legislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)drugLegislationMedicaidMedicareObamaResearchrheumatologistSGRTechnology

Expressing My Point of View Where it Matters Most—In the Halls of Congress

Herbert S. B. Baraf, MD  |  July 9, 2012

The change that we desire and need is possible in Washington, D.C.

Filed under:From the CollegeLegislation & AdvocacyProfessional TopicsProfiles Tagged with:AC&RAdvocacyAdvocating with YouAmerican College of Rheumatology (ACR)CongressLegislationPoliticsProfilerheumatologistRheumPAC

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)BiologicsdrugHealthcare ReformLegislationLupusmanaged careMedicareOsteoporosispatient careradiographResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA

Kathy Holliman  |  June 10, 2012

Detailed screening and treatment recommendations based on current evidence, extensive literature review.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesFrom the CollegeRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGlucocorticoidsGuidelinesLupusLupus nephritispatient careRheumatoid arthritisSystemic lupus erythematosustocilizumab

Medication Quick Guides Offer Infusion Staff a Streamlined Resource

Susan Richmond, MS, PA-C; Karla B. Jones, RN, MS, CPNP  |  June 10, 2012

The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.

Filed under:Biologics/DMARDsDrug UpdatesFrom the College Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiologicsdrugpharmacyresourceSafety

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel  |  May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

Filed under:Axial SpondyloarthritisConditionsProfilesResearch RheumRheumatoid Arthritis Tagged with:Ankylosing SpondylitisBiologicsCareerdrugProfileradiographResearchTraining

The American College of Rheumatology (ACR) can Help Combat Insurance Frustrations

James R. O’Dell, MD  |  April 6, 2012

When it comes to dealing with insurance companies, the rules seem to change frequently and always in an arbitrary and capricious way. The ACR is trying its best to protect rheumatologists, but we need your help!

Filed under:InsuranceLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/Improvement Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)druginsuranceLegislationLupusRheumatoid arthritisSystemic lupus erythematosus

American College of Rheumatology (ACR) Advocates for Improved Access to Critical Treatments

Staff  |  April 6, 2012

The ACR is promoting federal legislation to eliminate high cost sharing for specialty tier medications in all states.

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAdvocating with YouAmerican College of Rheumatology (ACR)BiologicsdrugLegislationpatient care

  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 75
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences